B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies

DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.1.526 that is spreading at an alarming rate in the New York City area. Two versions of the variant were identified, both with the prevalent D614G mutation in the spike protein, together with four novel point mutations and with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hao, Dcosta, Belinda M., Samanovic, Marie I., Mulligan, Mark J., Landau, Nathaniel R., Tada, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406170/
https://www.ncbi.nlm.nih.gov/pubmed/34311587
http://dx.doi.org/10.1128/mBio.01386-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406170/
https://www.ncbi.nlm.nih.gov/pubmed/34311587
http://dx.doi.org/10.1128/mBio.01386-21

Ejemplares similares